ETF Copilot
Health & Biotech

Is IXJ a good investment?

Updated October 28, 2026

iShares Global Healthcare ETF (IXJ) is a healthcare and biotech ETF. As of October 28, 2026, ETF Copilot scores IXJ 5.1 out of 10 — highest on Risk (8.1), lowest on Value (1.9). It trades at 29.7 times earnings, against its own median of 24.8. Its ten largest holdings are 48% of the fund.

What stands out in IXJ's data

Global healthcare sector stocks, from drugmakers to medical equipment.

Trades at a richer price than its own recent history — you pay more for the same earnings stream.

Trailing P/E multiple of 29.7x sits just above the category median of 29.6x and well above its own 24.8x historical median. Holdings number 123.

A global health-sector sleeve that can steady a portfolio through market cycles.

Why did IXJ move this week? It rose 0.5% in the week to October 28, 2026 — Johnson & Johnson and Genmab A/S drove it

IXJ rose 0.5% in the week to October 28, 2026. The holdings that moved it most were Johnson & Johnson (+5.1%), Genmab A/S (+46.4%) and Eli Lilly (+1.4%); Merck (−6.0%) pushed the other way.

How is IXJ rated? ETF Copilot scores iShares Global Healthcare ETF (IXJ) 5.1 out of 10

As of October 28, 2026, ETF Copilot scores iShares Global Healthcare ETF (IXJ) 5.1 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

  • Overall: 5.1 / 10
  • Growth: 5.2 / 10
  • Value: 1.9 / 10
  • Risk: 8.1 / 10
  • Quality: 7.2 / 10
  • Return: 3.8 / 10

Is IXJ expensive right now? It trades at 29.7 times earnings, against its own median of 24.8

As of October 28, 2026, IXJ is more expensive than 93% of its own last 9 years.

Trailing 12 months, built from IXJ's holdings. How we calculate this →

What's inside IXJ?

What's inside IXJ: Size (Large 93%, Mid 7%, Small 0%); Geography (International 28%, US 72%); AI 0.3%.

What are IXJ's top holdings? The ten largest are 48% of the fund

Eli Lilly, Johnson & Johnson, Abbvie, UnitedHealth, Merck, Roche, Novartis, AstraZeneca, Thermo Fisher Scientific and Amgen are IXJ's largest holdings, in that order.

Less concentrated than 58% of Health & Biotech ETFs.

Half of IXJ's weight sits in its 12 largest positions, and once those weights are taken into account it behaves like 30 equally weighted holdings.

What is IXJ's expense ratio? 0.38% a year

As of October 28, 2026, IXJ charges 0.38% a year, yields 1.33% and holds $4.5B in assets across 123 positions.

iShares Global Healthcare ETF (IXJ) — cost, income and size
MeasureIXJ
Expense ratio0.38%
Dividend yield1.33%
Assets under management$4.5B
Holdings123

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Cite this

ETF Copilot, “iShares Global Healthcare ETF (IXJ) scores and holdings analysis”, as of October 28, 2026.
https://etf-copilot.com/etf/ixj

ETF Copilot Pro unlocks IXJ's price and what each holding weighs.

Try Pro free →